Early increase of plasma homocysteine in sepsis patients with poor outcome.
Moderate hyperhomocysteinemia is a well-established coronary risk factor that develops when dietary supply with folate and/or vitamin B(12) is inadequate. Recently, stimulated peripheral blood mononuclear cells were shown to produce homocysteine. Thus, the stimulated immune system may contribute to moderate hyperhomocysteinemia during certain diseases. Because multiple trauma and sepsis are accompanied by often strong inflammatory responses, we investigated whether hyperhomocysteinemia may develop in patients. Total homocysteine and cysteine concentrations were measured in 83 plasma specimens from 18 patients (14 men, 4 women; 15 posttrauma with sepsis and 3 with sepsis alone) every third day of follow-up. Finally results were compared with concentrations of cytokines tumor necrosis factor (TNF)-α and interleukin (IL)-6, the immune activation marker neopterin and the extent of tryptophan degradation as indicated by the kynurenine-to-tryptophan ratio (kyn/trp). Compared with baseline, average total homocysteine (P < 0.05, d 4-d 10) and cysteine (P < 0.05, d 7-d 13) concentrations increased during follow-up of patients. However, only the increase of homocysteine was related to the survival status: total homocysteine was significantly higher in nonsurvivors (P < 0.05, d 4 and d 10) than in survivors, whereas cysteine concentrations increased in both subgroups. Homocysteine correlated with kyn/trp but not with neopterin concentrations. Increase of total homocysteine is common in patients after trauma with unfavorable outcome. Because all patients received standardized enteral nutrition after the end of hypodynamic shock, inconsistent vitamin supply is unlikely to be the reason for hyperhomocysteinemia in some of the patients; rather, it is associated with a stronger proinflammatory response. Certainly, the number of patients in our study is still small and results can only be regarded as preliminary.
Ploder
Martin
M
Department of Surgery, Medical University of Vienna, Vienna, Austria.
Kurz
Katharina
K
Spittler
Andreas
A
Neurauter
Gabriele
G
Roth
Erich
E
Fuchs
Dietmar
D
D000328:Adult; D015415:Biomarkers / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000276:immunology* / Q000378:metabolism; D015850:Interleukin-6 / Q000097:blood; D007737:Kynurenine / Q000097:blood; D008297:Male; D008875:Middle Aged; D019798:Neopterin / Q000097:blood; D018805:Sepsis / Q000150:complications* / Q000628:therapy*; D016896:Treatment Outcome; D014364:Tryptophan / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D055815:Young Adult
D015415:Biomarkers; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D006710:Homocysteine; D007737:Kynurenine; D019798:Neopterin; D014364:Tryptophan
J Exp Med. 1984 Jul 1;160(1):310-6
6429267
JAMA. 1995 Oct 4;274(13):1049-57
7563456
Alzheimer Dis Assoc Disord. 2004 Jul-Sep;18(3):129-33
15494618
Lancet. 1999 Jul 31;354(9176):407-13
10437885
Chest. 1992 Jun;101(6):1481-3
1600757
Shock. 2005 Mar;23(3):209-15
15718917
Int J Tryptophan Res. 2009;2:1-19
22084578
Curr Drug Metab. 2002 Apr;3(2):175-87
12003349
Clin Chem Lab Med. 2008;46(5):648-54
18839466
Atherosclerosis. 2009 Feb;202(2):543-9
18556000
Clin Chim Acta. 2003 May;331(1-2):19-23
12691859
Shock. 2003 Nov;20(5):420-6
14560105
Ann Intern Med. 1999 Sep 7;131(5):331-9
10475885
Crit Care Med. 1987 Aug;15(8):757-60
3497012
Clin Sci (Lond). 2009 Apr;116(7):593-8
18986303
Atherosclerosis. 2008 Nov;201(1):176-83
18336825
Clin Exp Immunol. 1999 Jun;116(3):435-40
10361231
Clin Chem Lab Med. 2001 Aug;39(8):691-4
11592434
Clin Chim Acta. 2003 Dec;338(1-2):157-64
14637281
Atherosclerosis. 2001 Aug;157(2):403-9
11472740
J Neural Transm (Vienna). 2006 Nov;113(11):1815-9
16988797
Curr Opin Crit Care. 2006 Dec;12(6):595-601
17077693
Biochem J. 1979 Mar 15;178(3):795-797
454383
Clin Chem Lab Med. 2003 Nov;41(11):1438-43
14656023
Clin Exp Immunol. 2003 Oct;134(1):53-6
12974754
Eur Heart J. 2005 Mar;26(5):457-63
15684278
J Leukoc Biol. 2002 Dec;72(6):1148-53
12488496
J Intern Med. 2007 Aug;262(2):244-53
17645592
J Exp Med. 1983 Sep 1;158(3):670-89
6411853
Clin Chem. 2007 May;53(5):807-9
17468406
N Engl J Med. 1998 Apr 9;338(15):1042-50
9535670
Am J Clin Nutr. 2007 Nov;86(5):1563S-8S
17991676
Clin Chem. 2001 Mar;47(3):403-11
11238289
Clin Chem Lab Med. 2007;45(9):1224-8
17635079